Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-10-10

Clinical Trial Update: Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder

View source ↗

Summary

This clinical trial update discusses evaluating aripiprazole for improving cognitive function in adolescents and young adults with psychotic disorders. The stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Psychotic Disorders | Status: UNKNOWN